Reported Earlier, Viridian Therapeutics Prices $225M Upsized Public Offering 10,666,600 Common Shares At $18.75/Share And Preferred Stock
Author: Benzinga Newsdesk | September 12, 2024 02:53am
Viridian is selling a total of 10,666,600 shares of common stock at a public offering price of $18.75 per share and 20,000 shares of Series B non-voting convertible preferred stock at a public offering price of $1,250.06250 per share, which are convertible into 1,333,400 shares of common stock, subject to beneficial ownership conversion limits. In addition, Viridian has granted the underwriters a 30-day option to purchase an additional 1,800,000 shares of common stock at the public offering price, less underwriting discounts and commissions.
Posted In: VRDN